Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,491 | 1,255 | 72.1% |
| Consulting Fee | $4,495 | 2 | 15.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 1 | 7.9% |
| Travel and Lodging | $1,124 | 1 | 4.0% |
| Education | $47.85 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INSYS Therapeutics Inc | $8,772 | 16 | $0 (2018) |
| ABBVIE INC. | $4,462 | 207 | $0 (2024) |
| Abbott Laboratories | $2,590 | 173 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,848 | 120 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,151 | 87 | $0 (2024) |
| PFIZER INC. | $1,007 | 102 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $869.19 | 64 | $0 (2022) |
| Daiichi Sankyo Inc. | $763.97 | 63 | $0 (2018) |
| Allergan, Inc. | $632.93 | 39 | $0 (2021) |
| Amgen Inc. | $580.06 | 33 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,547 | 107 | ABBVIE INC. ($434.09) |
| 2023 | $2,130 | 123 | ABBVIE INC. ($858.08) |
| 2022 | $3,306 | 177 | ABBVIE INC. ($1,501) |
| 2021 | $4,063 | 222 | AbbVie Inc. ($1,669) |
| 2020 | $2,483 | 168 | Abbott Laboratories ($644.55) |
| 2019 | $1,867 | 156 | Abbott Laboratories ($277.13) |
| 2018 | $2,095 | 138 | Collegium Pharmaceutical, Inc. ($293.72) |
| 2017 | $10,918 | 177 | INSYS Therapeutics Inc ($8,758) |
All Payment Transactions
1,268 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $11.31 | General |
| Category: Opioid Analgesic | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: PAIN | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/05/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: PAIN | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: PAIN | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: PAIN | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $8.88 | General |
| Category: Opioid Analgesic | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: PAIN | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: Opioid Analgesic | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: PAIN | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.96 | General |
| Category: Opioid Analgesic | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 533 | 1,638 | $166,224 | $114,627 |
| 2022 | 13 | 940 | 2,713 | $271,396 | $191,953 |
| 2021 | 20 | 1,294 | 4,241 | $444,626 | $315,478 |
| 2020 | 20 | 1,462 | 4,604 | $668,692 | $368,312 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 776 | $69,491 | $48,225 | 69.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 381 | $48,249 | $33,230 | 68.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 75 | 109 | $28,740 | $20,014 | 69.6% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Office | 2023 | 27 | 32 | $9,757 | $6,854 | 70.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 33 | 58 | $3,874 | $2,591 | 66.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $2,694 | $1,746 | 64.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 112 | 250 | $2,500 | $1,256 | 50.2% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 15 | 16 | $919.94 | $711.29 | 77.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 1,199 | $108,652 | $74,823 | 68.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 449 | $57,423 | $41,398 | 72.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 105 | 157 | $46,870 | $35,552 | 75.9% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Office | 2022 | 32 | 42 | $16,662 | $12,491 | 75.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 64 | 114 | $8,517 | $5,462 | 64.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 48 | 58 | $7,250 | $5,248 | 72.4% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 61 | 93 | $5,367 | $4,104 | 76.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 17 | 24 | $4,245 | $3,115 | 73.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $4,550 | $2,895 | 63.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 173 | 504 | $5,040 | $2,618 | 52.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 11 | 14 | $2,306 | $1,833 | 79.5% |
| 64480 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | Office | 2022 | 12 | 14 | $2,800 | $1,589 | 56.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 19 | $1,716 | $825.59 | 48.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 247 | 2,182 | $175,155 | $124,715 | 71.2% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 130 | 239 | $71,630 | $54,806 | 76.5% |
| 63650 | Implantation of spinal neurostimulator electrodes, accessed through the skin | Office | 2021 | 13 | 25 | $48,000 | $28,452 | 59.3% |
| 64484 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, each additional level | Office | 2021 | 126 | 229 | $28,625 | $20,938 | 73.1% |
About Dr. Nehal Modh, MD
Dr. Nehal Modh, MD is a Pain Medicine healthcare provider based in Festus, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619081890.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nehal Modh, MD has received a total of $28,407 in payments from pharmaceutical and medical device companies, with $1,547 received in 2024. These payments were reported across 1,268 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($20,491).
As a Medicare-enrolled provider, Modh has provided services to 4,229 Medicare beneficiaries, totaling 13,196 services with total Medicare billing of $990,369. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Festus, MO
- Active Since 08/18/2006
- Last Updated 10/08/2024
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1619081890
Products in Payments
- SUBSYS (Drug) $8,772
- UBRELVY (Drug) $3,870
- RELISTOR (Drug) $1,670
- NURTEC ODT (Drug) $1,305
- QULIPTA (Drug) $1,186
- Proclaim Family of SCS IPGs (Device) $783.25
- TROKENDI XR (Drug) $772.29
- PROCLAIM (Device) $772.14
- Aimovig (Biological) $580.06
- Movantik (Drug) $517.51
- Horizant (Drug) $476.44
- XTAMPZA (Drug) $443.51
- LYRICA (Drug) $349.68
- EMGALITY (Drug) $337.88
- Belbuca (Drug) $319.29
- Xtampza ER (Drug) $308.01
- BUNAVAIL 2.1 mg 30-count box (Drug) $294.52
- Proclaim IPG (Device) $285.26
- RELISTOR ORAL (Drug) $283.07
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $260.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.